200 filings
6-K
ASLN
ASLAN Pharmaceuticals Ltd
22 Apr 24
Aslan Pharmaceuticals Announces Positive Interim Results from Phase 2 Study of Eblasakimab In Dupilumab-experienced Atopic Dermatitis Patients
8:29am
6-K
ASLN
ASLAN Pharmaceuticals Ltd
19 Apr 24
Aslan Pharmaceuticals Announces Receipt of Nasdaq Notice
5:01pm
424B5
ASLN
ASLAN Pharmaceuticals Ltd
12 Apr 24
Prospectus supplement for primary offering
8:15am
6-K
ASLN
ASLAN Pharmaceuticals Ltd
12 Apr 24
Amendment No. 2 to the Open Market Sale Agreementsm
8:10am
S-8
ASLN
ASLAN Pharmaceuticals Ltd
12 Apr 24
Registration of securities for employees
6:37am
6-K
qq488qi1t2b5qpgofu
12 Apr 24
Aslan Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Corporate Update
6:05am
EFFECT
zjj1in5in2vl50nism
1 Apr 24
Notice of effectiveness
12:15am
D
f9exbb si2kwf8
28 Mar 24
$5.00 mm in options / securities to be acquired, sold $5.00 mm, 4 investors
2:11pm
F-3
g0rfe74x9roiifp3h5b
25 Mar 24
Shelf registration (foreign)
4:46pm
SC 13G
z202goex
21 Mar 24
ASLAN Pharmaceuticals / INTRACOASTAL CAPITAL ownership change
4:42pm
SC 13G
b606hjouo c1b1cjt
19 Mar 24
ASLAN Pharmaceuticals / Lind Global Fund II ownership change
4:30pm
424B5
e5okor3 y0
14 Mar 24
Prospectus supplement for primary offering
6:24am
6-K
0dmcknq5pcd uf
13 Mar 24
Aslan Pharmaceuticals Announces $5 Million Registered Direct Offering
7:27am
6-K
6u6e4hh v29tr
11 Mar 24
ASLAN PHARMACEUTICALS PROVIDES TREK-DX STUDY UPDATE AND HIGHLIGHTS potENTIAL of EBLASAKIMAB in DUPILUMAB-EXPERIENCED ATOPIC DERMATITIS PATIENTS
8:03am
SC 13G/A
yw7 joh5whz5jf5
14 Feb 24
ASLAN Pharmaceuticals / K2 HealthVentures Equity Trust ownership change
4:45pm
SC 13G/A
u4unt4 17
14 Feb 24
ASLAN Pharmaceuticals / BIOTECHNOLOGY VALUE FUND L P ownership change
10:22am
SC 13G
dv5zn 4fizt3hqi81
6 Feb 24
ASLAN Pharmaceuticals / UBS ownership change
10:38am
6-K
2rtpgp6jar
24 Jan 24
Current report (foreign)
7:52am
6-K
rz3ykyjafcmnl
8 Jan 24
Aslan Pharmaceuticals Announces Receipt of Nasdaq Deficiency Notice Regarding Minimum Bid Price Requirement
7:02am